Statistics
Publications
5
Citations
287
H-Index
5
Active since
2018
Affiliations
Guolong Xu is an author at Nanjing Medical University specializing in oncology, medicine, and molecular oncology.
Publications per year
2018–2022
5
5
CD24 regulates sorafenib resistance via activating autophagy in hepatocellular carcinoma
Shuai Lü, Yao Yao, Guolong Xu et al. · Cell Death and Disease · 2018 · 127 citations · Full text
Medicine, Oncology, Pharmacology +17
1–5 of 5